<em>RICTOR</em> Amplification in Lung Cancer
Bilal Piperdi, MD, discusses an analysis presented at the 2014 ASCO Annual Meeting that looked at RICTOR amplification to define a subset of patients with lung cancer.
Recent Advancements in Non-Small Cell Lung Cancer
Bilal Piperdi, MD, discusses the recent advancements in non-small cell lung cancer treatment and what the future might bring.
Molecular Targeted Agents for Stage III NSCLC
Bilal Piperdi, MD, Associate Professor of Clinical Medicine, Department of Medicine (Oncology), Albert Einstein College of Medicine, comments on molecular targeted agents for stage III non-small cell lung cancer (NSCLC).